ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma

Zhang, Lu; Jin, Zhe; Li, Chen; He, Zicong; Zhang, Bin; Chen, Qiuying; You, Jingjing; Ma, Xiao; Shen, Hui; Wang, Fei; Wu, Lingeng*; Ma, Cunwen*; Zhang, Shuixing*广州中医药大学; 1
Radiologia Medica2024-2-14DOI: 10.1007/s11547-024-01785-z
10阅读
引用收藏
分享

摘要

Objective To explore the potential of pre-therapy computed tomography (CT) parameters in predicting the treatment response to initial conventional TACE (cTACE) in intermediate-stage hepatocellular carcinoma (HCC) and develop an interpretable machine learning model. Methods This retrospective study included 367 patients with intermediate-stage HCC who received cTACE as first-line therapy from three centers. We measured the mean attenuation values of target lesions on multi-phase contrast-enhanced CT and further calculated three CT parameters, including arterial (AER), portal venous (PER), and arterial portal venous (APR) enhancement ratios. We used logistic regression analysis to select discriminative features and trained three machine learning models via 5-fold cross-validation. The performance in predicting treatment response was evaluated in terms of discrimination, calibration, and clinical utility. Afterward, a Shapley additive explanation (SHAP) algorithm was leveraged to interpret the outputs of the best-performing model. Results The mean diameter, ECOG performance status, and cirrhosis were the important clinical predictors of cTACE treatment response, by multiple logistic regression. Adding the CT parameters to clinical variables showed significant improvement in performance (net reclassification index, 0.318, P < 0.001). The Random Forest model (hereafter, RF-combined model) integrating CT parameters and clinical variables demonstrated the highest performance on external validation dataset (AUC of 0.800). The decision curve analysis illustrated the optimal clinical benefits of RF-combined model. This model could successfully stratify patients into responders and non-responders with distinct survival (P = 0.001). Conclusion The RF-combined model can serve as a robust and interpretable tool to identify the appropriate crowd for cTACE sessions, sparing patients from receiving ineffective and unnecessary treatments.

学科与关键词

关键词
Hepatocellular carcinomaConventional transarterial chemoembolizationComputed tomographyTreatment responseMachine learning
相关
加载中…
  • Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma
    Sun, Zhongqi; Shi, Zhongxing; Xin, Yanjie; Zhao, Sheng; Jiang, Hao; Li, Jinping; Li, Jiaping; Jiang, HuijieACADEMIC RADIOLOGY, 2023, 30: S81-S91.被引 4
  • Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie*; Huang, Jinhua*; Huang, Guijia; Zhang, JingFrontiers in Oncology, 2021, 11: 730282.被引 16
  • Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Wang, Dan-Dan; Zhang, Jin-Feng; Zhang, Lin-Han; Niu, Meng; Jiang, Hui-Jie*; Jia, Fu-Cang*; Feng, Shi-Ting*Hepatobiliary & Pancreatic Diseases International, 2023, 22(6): 594-604.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Radiologia Medica
发表日期
2024-02-14
DOI
10.1007/s11547-024-01785-z
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
National Key Research and Development Program of China

作者

  • Z

    Zhang, Lu (第一作者)

    1

  • J

    Jin, Zhe

    1

查看全部 13 位作者收起作者
  • L

    Li, Chen

    1

  • H

    He, Zicong

    1

  • Z

    Zhang, Bin

    1

  • C

    Chen, Qiuying

    1

  • Y

    You, Jingjing

    1

  • M

    Ma, Xiao

    1

  • S

    Shen, Hui

    1

  • W

    Wang, Fei

    1

  • W

    Wu, Lingeng (通讯)

    2 · guangzhou univ tradit chinese med

  • M

    Ma, Cunwen (通讯)

  • Z

    Zhang, Shuixing (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417